Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 31.8 USD -2.99% Market Closed
Market Cap: 882.1m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Wall Street
Price Targets

CSTL Price Targets Summary
Castle Biosciences Inc

Wall Street analysts forecast CSTL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSTL is 36.83 USD with a low forecast of 28.28 USD and a high forecast of 47.25 USD.

Lowest
Price Target
28.28 USD
11% Downside
Average
Price Target
36.83 USD
16% Upside
Highest
Price Target
47.25 USD
49% Upside

CSTL Last Price Targets
Castle Biosciences Inc

The latest public price target was made on Nov 5, 2024 by Catherine Schulte from Robert W. Baird , who expects CSTL stock to rise by 23% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Catherine Schulte
Robert W. Baird
39 USD
Upside 23%
1 week ago
Nov 5, 2024
Castle Biosciences (CSTL) PT Raised to $39 at Baird
StreetInsider
Paul Knight
KeyBanc
36 USD
Upside 13%
1 week ago
Nov 5, 2024
Castle Biosciences (CSTL) PT Raised to $36 at KeyBanc
StreetInsider
Sung Ji Nam
BTIG
45 USD
Upside 42%
1 week ago
Nov 5, 2024
Castle Biosciences (CSTL) PT Raised to $45 at BTIG
StreetInsider
Kyle Mikson
Canaccord Genuity
42 USD
Upside 32%
2 weeks ago
Oct 29, 2024
Castle Biosciences (CSTL) PT Raised to $42 at Canaccord Genuity
StreetInsider
Sung Ji Nam
BTIG
40 USD
Upside 26%
1 month ago
Oct 14, 2024
Castle Biosciences (CSTL) PT Raised to $40 at BTIG
StreetInsider
Sung Ji Nam
BTIG
35 USD
Upside 10%
3 months ago
Aug 6, 2024
Castle Biosciences (CSTL) PT Raised to $35 at BTIG
StreetInsider
Show More Price Targets
Show Less Price Targets
Catherine Schulte
Robert W. Baird
Price Target 39 USD
Upside/Downside 23%
View Source
Paul Knight
KeyBanc
Price Target 36 USD
Upside/Downside 13%
View Source
Sung Ji Nam
BTIG
Price Target 45 USD
Upside/Downside 42%
View Source
Kyle Mikson
Canaccord Genuity
Price Target 42 USD
Upside/Downside 32%
View Source
Sung Ji Nam
BTIG
Price Target 40 USD
Upside/Downside 26%
View Source
Sung Ji Nam
BTIG
Price Target 35 USD
Upside/Downside 10%
View Source
Show More Price Targets
Show Less Price Targets
Castle Biosciences Inc Competitors:
Price Targets
KRSNAA
Krsnaa Diagnostics Ltd
1% Upside
PRDA
Prodia Widyahusada Tbk PT
54% Upside
DNTL
dentalcorp Holdings Ltd
10% Upside
AIRS
Airsculpt Technologies Inc
46% Downside
AIDX
Healwell Al Inc
131% Upside
OPTIMAX
Optimax Holdings Bhd
31% Upside
V3V
Vita 34 AG
61% Upside
METROPOLIS
Metropolis Healthcare Ltd
2% Upside

Revenue
Forecast

Revenue Estimate
Castle Biosciences Inc

For the last 5 years the compound annual growth rate for Castle Biosciences Inc's revenue is 57%. The projected CAGR for the next 3 years is 12%.

57%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Castle Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Castle Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSTL's stock price target?
Price Target
36.83 USD

According to Wall Street analysts, the average 1-year price target for CSTL is 36.83 USD with a low forecast of 28.28 USD and a high forecast of 47.25 USD.

What is Castle Biosciences Inc's Revenue forecast?
Projected CAGR
12%

For the last 5 years the compound annual growth rate for Castle Biosciences Inc's revenue is 57%. The projected CAGR for the next 3 years is 12%.

Back to Top